药品
药物输送
药理学
材料科学
体内
毒品携带者
壳聚糖
赫拉
细胞毒性
癌症研究
纳米技术
医学
化学
体外
生物
生物化学
生物技术
作者
Shichao Wu,Xiangrui Yang,Yue Lu,Zhongxiong Fan,Yang Li,Yuan Ying Jiang,Zhenqing Hou
出处
期刊:Drug Delivery
[Taylor & Francis]
日期:2017-01-01
卷期号:24 (1): 51-60
被引量:34
标识
DOI:10.1080/10717544.2016.1228716
摘要
Exploration of efficient dual-drug nanohybrids, particularly those with high drug loading, specific targeting property, and long-termed stability, is of highly importance in cancer therapy. A pH-driven coprecipitation was performed in the aqueous phase to obtain a dual-drug nanoformulation, composed of 10-hydroxycamptothecine (HCPT) nanoneedles integrated with an exterior thin layer of the methotrexate (MTX)-chitosan conjugate. The high stability of nanohybrids in water and the targeting property provided by the MTX ingredient function synergistically to the prolonged and sustained drug release property in tumor tissues and the increased cellular uptake. The cytotoxicity test illustrates that dual-drug nanoneedles possess the remarkable killing ability to HeLa cells with the combination index at 0.33 ± 0.07. After cellular internalization, the release of both drug ingredients results in an excellent anticancer activity in vivo with the minimized adverse side effects. Design of a green approach to the carrier-free, dual-drug nanoformulations enables to develop emerging drug delivery systems for cancer diagnosis and treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI